Article Versions Notes

Fruhauf S, Novak B, Nagl V, Hackl M, Hartinger D, Rainer V, Labudová S, Adam G, Aleschko M, Moll W-D, et al. Biotransformation of the Mycotoxin Zearalenone to its Metabolites Hydrolyzed Zearalenone (HZEN) and Decarboxylated Hydrolyzed Zearalenone (DHZEN) Diminishes its Estrogenicity In Vitro and In Vivo. Toxins. 2019; 11(8):481. https://doi.org/10.3390/toxins11080481

Fruhauf, Sebastian, Barbara Novak, Veronika Nagl, Matthias Hackl, Doris Hartinger, Valentina Rainer, Silvia Labudová, Gerhard Adam, Markus Aleschko, Wulf-Dieter Moll, and et al. 2019. "Biotransformation of the Mycotoxin Zearalenone to its Metabolites Hydrolyzed Zearalenone (HZEN) and Decarboxylated Hydrolyzed Zearalenone (DHZEN) Diminishes its Estrogenicity In Vitro and In Vivo" Toxins 11, no. 8: 481. https://doi.org/10.3390/toxins11080481

Fruhauf, S., Novak, B., Nagl, V., Hackl, M., Hartinger, D., Rainer, V., Labudová, S., Adam, G., Aleschko, M., Moll, W. -D., Thamhesl, M., & Grenier, B. (2019). Biotransformation of the Mycotoxin Zearalenone to its Metabolites Hydrolyzed Zearalenone (HZEN) and Decarboxylated Hydrolyzed Zearalenone (DHZEN) Diminishes its Estrogenicity In Vitro and In Vivo. Toxins, 11(8), 481. https://doi.org/10.3390/toxins11080481